Pyrimidine

Pyrimidine

SCHEMBL5524828

O=C(O)c1cnc2ccccc2c1NCCCNc1ncccn1.c1cncnc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.46
PKM P14618 1/20 0.46
KMT2A Q03164 1/20 0.46
POLB P06746 1/20 0.40
RAD52 P43351 1/20 0.40
HPGD P15428 1/20 0.39
ASPH Q12797 2/20 0.39
KDM8 Q8N371 2/20 0.39
MAPT P10636 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
TOP2A P11388 2/20 0.38
MAPK8 P45983 1/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
KDM6B O15054 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
TP53 P04637 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5981802 0.94 MEN1 (0.50) MEN1PKMKMT2APOLBRAD52
SCHEMBL2052464 0.79 MEN1 (0.57) MEN1PKMKMT2APOLBRAD52
SCHEMBL5508099 0.77 MEN1 (0.47) MEN1PKMKMT2APOLBRAD52
SCHEMBL5500673 0.76 KMT2A (0.72) MEN1PKMKMT2APOLBRAD52
SCHEMBL5502811 0.74 MEN1 (0.47) MEN1PKMKMT2APOLBRAD52
SCHEMBL5506961 0.72 MEN1 (0.49) MEN1PKMKMT2APOLBRAD52
SCHEMBL18998176 0.70 ALDH1A1 (0.48) MEN1PKMKMT2AHPGDMAPT
SCHEMBL4788245 0.69 CSF1R (0.56) MAPTKDM4EALDH1A1TP53SMN1; SMN2
SCHEMBL7540120 0.68 PTPN1 (0.45) MEN1PKMKMT2AHPGDMAPT
SCHEMBL1959406 0.67 POLB (0.46) MEN1PKMKMT2APOLBRAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1753724-A1 HETEROCYCLIC DERIVATIVES FOR TREATMENT OF HYPERLIPIDEMIA AND RELATED DISEASES AVANIR PHARMACEUTICALS (US) 2007-02-21 EP disclosed
WO-2005123686-A1 HETEROCYCLIC DERIVATIVES FOR TREATMENT OF HYPERLIPIDEMIA AND RELATED DISEASES AVANIR PHARMACEUTICALS (US) 2005-12-29 WO disclosed